BTSG · BrightSpring Health Services, Inc.
$63.75
+1.75 (+2.82%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$11.02B
Shares
197.86M
Volume · Oct 6
3.12M
Avg daily vol (3M)
3.22M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$63.75
Open$62.97
Day$62.97–65.64
52W close$28.36–72.91
Avg vol 30d2.6M
Short int10.2M · 5.1% float · 4.6d
Short vol85%
Last earningsOct 30, 2026
DataJan 2024–Oct 2026
Filing10-Q · Jul 31
Up next
Next earnings release
Oct 30, 2026
Announced
· in 3 wks
Next earnings call
Oct 30, 2026
Scheduled
· in 3 wks
filed Jul 31, 2026
call held Jul 31, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$14.37B
Trailing 12 months
Net income (TTM)
$365.97M
Trailing 12 months
Revenue growth YoY
+23.0%
Year over year
Operating margin
3.1%
Trailing 12 months
P / E (TTM)
37.6
Trailing earnings · reciprocal yield 2.7%
FCF yield
3.7%
TTM · current market cap
Return on invested capital
10.2%
Trailing 12 months
Net cash
−$1.64B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.8%
Year over year · more shares
Price change (1Y)
+118.6%
Trailing year
Short interest
5.1%
Latest settlement · 4.6 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 15 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+21%
above
Price vs 50-day avg
+6%
above
RSI (14)
65
neutral
MACD trend
Positive
52-week position
79%
mid-range
Momentum
relative strength
1-month return
+2%
trailing
6-month return
+39%
trailing
YTD return
+70%
this year
Relative strength
+27%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $60 › 200d $53 — 50d above 200d
Institutional flow
Distributing
5 of 443 funds reported for Sep 30 · net -861 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.15% of float · ▲ +0.4% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
443 holders — near 2-yr high, broad support
Squeeze score
60
elevated · 0–100
Fundamentals
Revenue growth
+28%
Y/Y
Gross margin
12%
contracting
EPS growth
+1067%
Y/Y
Free cash flow
$394.7M
Valuation
P/E 33.8
below peers
Balance sheet
$2.4B
net debt
Quant / Vol
risk profile
Volatility
44%
annualized · 1-yr
Max drawdown
−24%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 31, 2026
Revenues
· full year 2026
Initiated
$15.1B – $15.43B
prior FY $12.91B
midpoint +18.2% Y/Y
Pharmacy Segment Revenue
· full year 2026
Initiated
$13.2B – $13.5B
Provider Segment Revenue
· full year 2026
Initiated
$1.9B – $1.93B
Total Adjusted EBITDA
· full year 2026
Non-GAAP
Initiated
$820M – $845M
Guided vs delivered
· last 1 settled
Net revenue
full year 2024
guided $10.45B – $10.9B
$10.07B
Miss −5.6%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+21%
Bullish
Price vs 50-day avg
+6%
Bullish
RSI (14)
65
Neutral
MACD trend
Positive
Bullish
52-week position
79%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $60 › 200d $53 — 50d above 200d
Institutional flow
Distributing
5 of 443 funds reported for Sep 30 · net -861 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.15% of float · ▲ +0.4% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
443 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $28
Now $64 · 79%
Range high $73
vs 200-day avg +21%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BTSG
this stock
BrightSpring Health Services, Inc.
|
$11.02B | +70.2% | +28.2% | 33.8 | 5.1% |
|
VEEV
Veeva Systems Inc
|
$45.44B | +27.0% | +28.1% | 45.9 | 3.1% |
|
TEM
Tempus AI, Inc.
|
$15.34B | +21.9% | +83.4% | — | 15.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$12.20B | -29.7% | — | — | 0.0% |
|
HNGE
Hinge Health, Inc.
|
$7.71B | +111.7% | +50.6% | 71.8 | 6.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BTSG | +14.5% | +1.9% | +38.6% | +12.3% | +70.2% |
| SPY | +2.0% | +1.7% | +11.3% | +2.2% | +14.3% |
| vs SPY | +12.5% | +0.2% | +27.3% | +10.2% | +56.0% |
Key facts
CIK
1865782
CUSIP
10950A106
13F (30d)
11 filings
10 filers
Visit website
Investor relations